May 7, 2023
Katie Shen
Share
https://pubmed.ncbi.nlm.nih.gov/36515952/
Should HBV genotype be considered in determining who to surveil for HCC?
March 21, 2022
CheckMate 9DW Trial: Nivolumab + Ipilimumab for Unresectable HCC
August 17, 2026
Linerixibat for Cholestatic Pruritus in PBC: Phase 3 Results from the GLISTEN Trial
July 13, 2026